Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23991)

• Formulation Name: Ruxolitinib Phosphate eq 20mg base tablet
• Company: yte Corp

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ruxolitinib	(DM7Q98D)	Essential thrombocythemia	3B63.1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Hydroxypropyl cellulose	(E00632)	Not Available	Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent